After a brutal 52.7% share price decline over the past year, GoDaddy (NYSE: GDDY) is trading near multi-year lows. We analyze whether the sell-off has created a deep-value opportunity for investors or if fundamental challenges justify the market's pessimism.
Shares of Pathward Financial (NASDAQ: CASH) have surged over 25% year-to-date, prompting investors to question whether the rally has left the stock overvalued. We examine the numbers behind two key valuation frameworks to assess if there's still room for growth.
As Washington braces for a potential partial government shutdown, on-chain data reveals a mysterious trader has placed an $82 million leveraged short on Ethereum, echoing patterns of large bets ahead of past political crises.
President Trump's pick to lead the Federal Reserve, former governor Kevin Warsh, advocates for a dramatic shift in central bank strategy—shrinking its balance sheet—as the key to lowering mortgage rates, a move that challenges prevailing economic orthodoxy.
Recent buying activity by multiple executives at AdNeo Limited suggests internal optimism about the company's trajectory, even as its stock trades below their purchase price.
Altria Group expects improved second-half earnings by leveraging a U.S. tobacco tax rebate tied to increased exports, as the Marlboro maker seeks new avenues for growth in a shrinking cigarette market.
The consumer goods giant reported stronger-than-expected Q4 results, citing growth across key metrics despite inflationary pressures. As it rolls out its ambitious 2030 growth plan, management warns of a volatile global operating environment in the year ahead.
Citi analyst Geoff Meacham raised his price target on Bristol-Myers Squibb (BMY) to $60, citing a more favorable setup for the sector. The move comes as the drugmaker also announces a partnership with Microsoft to leverage AI for earlier lung cancer detection.
NextEra Energy's unique dual-business model offers investors the stability of a regulated utility alongside the high-growth potential of its renewable energy arm, positioning it as a key player in powering the AI boom.
A prominent crypto analyst warns that Bitcoin could retest a critical long-term support level near $57,000, signaling a deepening correction as the digital asset market stumbles into 2026.
Tunisian President Kais Saied has prolonged the nation's state of emergency for an additional 11 months, maintaining exceptional powers first enacted in 2015 following a deadly attack on presidential guards.
President Trump's reported selection of former Fed Governor Kevin Warsh to lead the central bank signals a potential shift in monetary policy approach, with a focus on strategic foresight over data-dependency, according to economist Mohamed El-Erian.
Shares of Heidelberg Materials have delivered stellar returns, more than tripling over three years. As the stock consolidates near recent highs, investors are questioning whether the rally has priced in future growth or if significant value remains. A deep dive into valuation metrics suggests the latter.
B. Riley analyst Craig Ellis has upgraded Rigetti Computing (NASDAQ: RGTI) from 'Neutral' to 'Buy', maintaining a $35 price target. The upgrade follows the company's announcement of an $8.4 million order to supply a 108-qubit quantum computer to India's premier R&D agency, C-DAC, providing clearer visibility into its 2026 commercial trajectory.
Box, Inc. strengthens its enterprise cloud offerings with the general release of Box Extract, an AI-driven data intelligence tool. The launch coincides with bullish analyst sentiment, including a Citi price target suggesting significant upside.
The global lifestyle retailer MINISO continues its aggressive capital return strategy, repurchasing millions of shares under a Rule 10b5-1 program as analysts remain bullish on the stock's outlook.
Live cattle futures gained ground Friday, supported by steady cash trade, while feeder cattle contracts faced significant pressure. Market attention turns to the upcoming USDA Cattle Inventory report, expected to show a slight decline in total herd numbers.
While premium valuations often signal strong growth, they also set the stage for sharp corrections when investor sentiment cools. We examine three stocks where sky-high expectations may be outpacing fundamentals.
As Appen announces a key governance change, its surging share price collides with deep long-term losses, forcing a hard look at whether this AI data play is a turnaround story or a value trap.
Analyst Tara Bancroft of TD Cowen lowered the firm's price target on Geron Corporation (GERN) from $4 to $3, maintaining a Buy rating ahead of the biotech's fourth-quarter results. The move reflects a model update as the company navigates mixed commercial progress for its blood cancer drug RYTELO.
